Tarun Wadhwa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tarun Wadhwa has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Rishabha Malviya
Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, India
10 shared publications Javedh Shareef
7 shared publicationsSathvik Belagodu Sridhar
7 shared publications- Javedh Shareef
RAK College of Pharmacy, RAK Medical & Health Sciences University, Ras al Khaimah P.O. Box 11172, United Arab Emirates
4 shared publications - Sathvik Belagodu Sridhar
College of Pharmacy, Dubai Medical University, Dubai P.O. Box 20170, United Arab Emirates
4 shared publications Shivam Rajput
3 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by Elsevier in Global Pediatrics
- Vol. 18
Translational advances in nanoparticle-mediated gene delivery for pediatric brain tumors: A structured narrative review
- 24 September 2026
- Published by Elsevier in Global Pediatrics
- Vol. 18
Open AccessTranslational advances in nanoparticle-mediated gene delivery for pediatric brain tumors: A structured narrative review
- 18 August 2026
- Published by Wiley in Polymers for Advanced Technologies
- Vol. 37 (8) , e70714
Physicochemical Science of Electrospun Nanofibers as Drug Delivery Systems for Improved Clinical Outcomes
Nanofiber technology is a revolutionary platform for drug delivery due to its unique physicochemical characteristics, including a high surface‐to‐volume ratio, adjustable porosity, modifiable mechanical strength, and customizable surface chemistry. Combining nanoscale physics and polymer chemistry allows the directed loading, release rates and interaction with biology to be controlled. This review critically examines the underlying physics and chemistry of nanofiber manufacturing and their effects on drug delivery, transport, biological behavior, and clinical translation potential. A literature‐based study was undertaken that was based upon the principles of electrospinning, the chemistry of polymers, incorporation of drugs, kinetics of drug transport, mathematical models, physicochemical characterization, biological interactions and emerging multifunctional nanofiber systems. Diffusion and polymer degradation are the most important mechanisms that determine the release of drugs through nanofibers and are highly dependent on the morphology, porosity, hydrophilicity, and molecular interactions of the nanofibers. The recent developments in stimuli‐responsive and hybrid nanofiber systems also allow the targeted, personalized, and controlled delivery of therapeutics. The interactive combination of physics‐based structural engineering and chemistry‐based functional modification offers an efficient framework for developing the next‐generation nanofiber‐based drug delivery systems. Nevertheless, even with the issues of scalability and regulation, innovations are increasing at a rate that makes them clinically applicable.
- 18 August 2026
- Published by Wiley in Polymers for Advanced Technologies
- Vol. 37 (8) , e70714
Physicochemical Science of Electrospun Nanofibers as Drug Delivery Systems for Improved Clinical Outcomes
Nanofiber technology is a revolutionary platform for drug delivery due to its unique physicochemical characteristics, including a high surface‐to‐volume ratio, adjustable porosity, modifiable mechanical strength, and customizable surface chemistry. Combining nanoscale physics and polymer chemistry allows the directed loading, release rates and interaction with biology to be controlled. This review critically examines the underlying physics and chemistry of nanofiber manufacturing and their effects on drug delivery, transport, biological behavior, and clinical translation potential. A literature‐based study was undertaken that was based upon the principles of electrospinning, the chemistry of polymers, incorporation of drugs, kinetics of drug transport, mathematical models, physicochemical characterization, biological interactions and emerging multifunctional nanofiber systems. Diffusion and polymer degradation are the most important mechanisms that determine the release of drugs through nanofibers and are highly dependent on the morphology, porosity, hydrophilicity, and molecular interactions of the nanofibers. The recent developments in stimuli‐responsive and hybrid nanofiber systems also allow the targeted, personalized, and controlled delivery of therapeutics. The interactive combination of physics‐based structural engineering and chemistry‐based functional modification offers an efficient framework for developing the next‐generation nanofiber‐based drug delivery systems. Nevertheless, even with the issues of scalability and regulation, innovations are increasing at a rate that makes them clinically applicable.
- Open Access
- 10 August 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Public knowledge and practices regarding the reuse and storage of leftover medications in the United Arab Emirates: a cross-sectional survey
- 10 August 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessPublic knowledge and practices regarding the reuse and storage of leftover medications in the United Arab Emirates: a cross-sectional survey
- Open Access
- 4 March 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (5) , 648
Prevalence and Associated Factors of Polypharmacy Among Emirati Community-Dwelling Older Adults: A Cross-Sectional Survey
Background/Objectives: Older adults are vulnerable to inappropriate prescribing and polypharmacy, yet data from the United Arab Emirates are scarce. We estimated the prevalence and correlates of polypharmacy and hyper-polypharmacy among Emirati community-dwelling older adults. Methods: A cross-sectional study of 200 Emiratis aged ≥60 years registered at primary health centers in Ras Al Khaimah used convenience sampling. Data on chronic conditions, medications, and function (Katz Index of Independence in Activities of Daily Living [Katz ADL]; Lawton Instrumental Activities of Daily Living scale [Lawton IADL]) were collected using a structured Arabic questionnaire. Polypharmacy was defined as 5–9 and hyper-polypharmacy as ≥10 medications. Results: Overall, 60% used 5–9 and 40% ≥10 medications; 90% had ≥1 chronic disease and 83% used non-prescribed drugs, commonly analgesics, vitamins, and laxatives. Higher medication burden was associated with poorer ADL and IADL. Younger age and lower Katz ADL scores predicted hyper-polypharmacy. Conclusions: Polypharmacy is highly prevalent and linked to functional limitations, supporting routine medication review, deprescribing, and monitoring of non-prescribed use.
- 4 March 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (5) , 648
Open AccessPrevalence and Associated Factors of Polypharmacy Among Emirati Community-Dwelling Older Adults: A Cross-Sectional Survey
Background/Objectives: Older adults are vulnerable to inappropriate prescribing and polypharmacy, yet data from the United Arab Emirates are scarce. We estimated the prevalence and correlates of polypharmacy and hyper-polypharmacy among Emirati community-dwelling older adults. Methods: A cross-sectional study of 200 Emiratis aged ≥60 years registered at primary health centers in Ras Al Khaimah used convenience sampling. Data on chronic conditions, medications, and function (Katz Index of Independence in Activities of Daily Living [Katz ADL]; Lawton Instrumental Activities of Daily Living scale [Lawton IADL]) were collected using a structured Arabic questionnaire. Polypharmacy was defined as 5–9 and hyper-polypharmacy as ≥10 medications. Results: Overall, 60% used 5–9 and 40% ≥10 medications; 90% had ≥1 chronic disease and 83% used non-prescribed drugs, commonly analgesics, vitamins, and laxatives. Higher medication burden was associated with poorer ADL and IADL. Younger age and lower Katz ADL scores predicted hyper-polypharmacy. Conclusions: Polypharmacy is highly prevalent and linked to functional limitations, supporting routine medication review, deprescribing, and monitoring of non-prescribed use.
- Open Access
- 22 January 2026
- Published by Elsevier in Journal of Trace Elements and Minerals
- Vol. 16
Gallium-infused nanomaterials for cancer theranostics and biosensing: Advancement and translation outlooks
- 22 January 2026
- Published by Elsevier in Journal of Trace Elements and Minerals
- Vol. 16
Open AccessGallium-infused nanomaterials for cancer theranostics and biosensing: Advancement and translation outlooks
- Open Access
- 20 December 2025
- Published by Elsevier in Additive Manufacturing Frontiers
- Vol. 5 (1)
Development from 4D bioprinting to 5D bioprinting: Advancements in tissue engineering and biomedical applications
- 20 December 2025
- Published by Elsevier in Additive Manufacturing Frontiers
- Vol. 5 (1)
Open AccessDevelopment from 4D bioprinting to 5D bioprinting: Advancements in tissue engineering and biomedical applications
- Open Access
- 15 August 2025
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis Open
- Vol. 6
Erythrocyte-derived nanosystems for biosensing: A green approach for analysis
- 15 August 2025
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis Open
- Vol. 6
Open AccessErythrocyte-derived nanosystems for biosensing: A green approach for analysis
- 8 July 2025
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 398 (12) , 16599-16626
Exosomal peptides and proteins in wound healing and skin regeneration
Wound healing is a highly coordinated biological process that includes inflammation, angiogenesis, proliferation, and tissue remodeling. Chronic wounds, comprising diabetic foot ulcers as well as pressure ulcers, present significant healthcare challenges due to prolonged healing and susceptibility to infections. Traditional treatments often fail to modulate the wound microenvironment, leading to suboptimal outcomes. Recent advancements highlight the potential of exosomal peptides and proteins in enhancing skin regeneration and wound repair. Exosomes are extracellular vesicles released by various cells, containing bioactive molecules like proteins, peptides, growth factors, and microRNAs, which regulate wound healing. Exosomal proteins contribute to angiogenesis by stimulating vascular endothelial growth factor and transforming growth factor-β, while heat shock proteins and matrix metalloproteinases facilitate extracellular matrix remodeling. Exosomal peptides and proteins offer a promising cell-free method for enhancing the healing of wounds and the regeneration of the skin. The present review sheds light on the therapeutic possibilities of exosomal peptides and proteins in wound healing, focusing on their mechanisms, biological effects, clinical applications, and challenges along with their future. Graphical Abstract
- 8 July 2025
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 398 (12) , 16599-16626
Exosomal peptides and proteins in wound healing and skin regeneration
Wound healing is a highly coordinated biological process that includes inflammation, angiogenesis, proliferation, and tissue remodeling. Chronic wounds, comprising diabetic foot ulcers as well as pressure ulcers, present significant healthcare challenges due to prolonged healing and susceptibility to infections. Traditional treatments often fail to modulate the wound microenvironment, leading to suboptimal outcomes. Recent advancements highlight the potential of exosomal peptides and proteins in enhancing skin regeneration and wound repair. Exosomes are extracellular vesicles released by various cells, containing bioactive molecules like proteins, peptides, growth factors, and microRNAs, which regulate wound healing. Exosomal proteins contribute to angiogenesis by stimulating vascular endothelial growth factor and transforming growth factor-β, while heat shock proteins and matrix metalloproteinases facilitate extracellular matrix remodeling. Exosomal peptides and proteins offer a promising cell-free method for enhancing the healing of wounds and the regeneration of the skin. The present review sheds light on the therapeutic possibilities of exosomal peptides and proteins in wound healing, focusing on their mechanisms, biological effects, clinical applications, and challenges along with their future. Graphical Abstract
- 25 June 2025
- Published by Elsevier in Journal of Clinical Orthopaedics and Trauma
- Vol. 68, 103113
IoT-enabled medical advances shaping the future of orthopaedic surgery and rehabilitation
- 25 June 2025
- Published by Elsevier in Journal of Clinical Orthopaedics and Trauma
- Vol. 68, 103113
IoT-enabled medical advances shaping the future of orthopaedic surgery and rehabilitation
- Top Cited PapersOpen Access
- 10 May 2025
- Published by Elsevier in New Microbes and New Infections
- Vol. 65, 101596
The emergence of oropouche fever: A potential new threat?
- 10 May 2025
- Published by Elsevier in New Microbes and New Infections
- Vol. 65, 101596
Top Cited PapersOpen AccessThe emergence of oropouche fever: A potential new threat?